Companion Diagnostic for ROS1-Positive Lung Cancer Approved
FoundationOne CDx has been approved by the FDA to be used as a companion diagnostic for the two indications of Rozlytrek (entrectinib).
Read More
Search Results for: lung cancer
Blood Biomarker More Accurately Predicts Lung Cancer Immunotherapy Response than Tumor Biopsy
A simple blood test could be an ideal predictor of whether cancer immunotherapy will be successful for a lung cancer patient.
Read More
CorePath Partners with Cizzle Biotech to Develop Early Lung Cancer Detection Test
CorePath is partnering with Cizzle Biotechnology to develop and offer a proprietary early-stage lung cancer blood test for the U.S.
Read More
Researchers Develop Model to Detect & Combat Lung Cancer Recurrence
Researchers found a process to study the actions of circulating tumor cells responsible for cancer recurrence of non-small cell lung cancer.
Read More
Blood Test Helps Identify Who Needs Lung Cancer Assessment
A blood test in tandem with reviewing an individual’s smoking history can more accurately determine if they may benefit from lung cancer screening.
Read More